文献速递术前评估与围术期医学神经外科与老年麻醉

吸入麻醉与靶控或手动全凭静脉麻醉的安全性和恢复特征:随机对照试验的系统综述与荟萃分析

Safety and recovery profile of patients after inhalational anaesthesia versus target-controlled or manual total intravenous anaesthesia: a systematic review and meta-analysis of randomised controlled trials.
PubMed 文献 · Br J Anaesth · 2025-03-11

该系统综述与荟萃分析纳入385项随机对照试验,比较全凭静脉麻醉(TIVA)与吸入麻醉(IA)的安全性及恢复相关结局。结果显示两组ClassIntra 3-4级不良事件无显著差异(RR 1.00,95%CI 0.88-1.12,P=0.97),TIVA减少术后恶心呕吐和躁动,而IA恢复更快、成本更低。

要点

  • TIVA与IA在ClassIntra 3-4级不良事件方面安全性相当(RR 1.00,95%CI 0.88-1.12)。
  • TIVA降低术后恶心呕吐和苏醒期躁动发生率。
  • IA在恢复时间和成本方面更具优势。

核心结论

  • TIVA与IA安全性相当,TIVA减少术后恶心呕吐和躁动,IA恢复更快且成本更低。
  • TIVA中使用靶控输注可能减少术后认知功能障碍并延长恢复时间。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Embase、Cochrane CENTRAL和Web of Science从建库至2024年10月10日。
  • 共纳入385项随机对照试验,比较TIVA与IA的患者相关及效率结局。

主要发现

  • TIVA与IA的ClassIntra 3-4级不良事件无显著差异(RR 1.00,95%CI 0.88-1.12;P=0.97)。
  • 亚组分析显示靶控输注组(RR 0.89,95%CI 0.66-1.21;P=0.46)和手动输注组(RR 1.03,95%CI 0.90-1.17;P=0.70)均无显著差异。
  • IA在恢复时间和成本方面更优,TIVA在术后恶心呕吐和苏醒期躁动发生率方面更优。

临床怎么用

  • 对于术后恶心呕吐高风险患者,可优先考虑TIVA以减少其发生率。
  • 需快速恢复或成本受限时,IA可能是更优选择。
  • TIVA中靶控输注与手动输注的选择需权衡术后认知功能障碍与恢复时间。

局限性

  • 缺乏直接比较TIVA中靶控输注与手动输注的系统综述,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the UK, total intravenous anaesthesia (TIVA) is used in 25% of general anaesthetics and is gaining traction because of its lower environmental impact and effectiveness in reducing postoperative nausea and vomiting (PONV). Although meta-analyses have compared TIVA and inhalational anaesthesia (IA), the optimal delivery method-manual infusion or target-controlled infusion (TCI)-remains underexplored. This review addresses this gap, leveraging the rapidly growing body of evidence to guide optimal anaesthetic practice. METHODS: We searched PubMed, Embase, Cochrane CENTRAL and Web of Science from inception to October 10, 2024. Studies comparing TIVA and IA across several patient-related and efficiency outcomes were included. Meta-analyses were performed for all outcomes. Subgroup analyses were performed to assess the contribution of different factors including a comparison of TCI with manual infusion in TIVA. RESULTS: In total, 385 RCTs were included. No significant difference in ClassIntra grade 3-4 adverse events was observed between TIVA and IA (risk ratio [RR]: 1.00, 95% confidence interval [CI]: 0.88-1.12; P=0.97). Subgroup analysis also showed no significant difference for TCI (RR: 0.89, 95% CI: 0.66-1.21; P=0.46) or manual infusion (RR: 1.03, 95% CI: 0.90-1.17; P=0.70) groups. IA was favoured in recovery times and costs, whereas the incidence of PONV and agitation on emergence favoured TIVA. No statistical difference was observed in our other outcomes. CONCLUSIONS: TIVA and IA are comparably safe, with TIVA reducing PONV and agitation, whereas IA offers faster recovery and lower costs. The use of TCI in TIVA might decrease postoperative cognitive dysfunction and increase recovery time, highlighting the need for a systematic review directly comparing TCI and manual infusion. SYSTEMATIC REVIEW PROTOCOL: This review was registered prospectively with PROSPERO (CRD42024413368) on October 10, 2024. A single amendment to the title and order of outcomes was performed on November 21, 2024.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Daccache N, Wu Y, Jeffries SD, et al. Safety and recovery profile of patients after inhalational anaesthesia versus target-controlled or manual total intravenous anaesthesia: a systematic review and meta-analysis of randomised controlled trials. Br J Anaesth. 2025. PMID: 40074622. doi:10.1016/j.bja.2025.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。